LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the specific mechanism of the disease remains unknown, and effective treatments are still lacking. It was reported that Nuclear enriched abundant transcript 1 (NEAT1) obvious...
Saved in:
Published in | Life sciences (1973) Vol. 235; p. 116829 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Inc
15.10.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0024-3205 1879-0631 1879-0631 |
DOI | 10.1016/j.lfs.2019.116829 |
Cover
Abstract | Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the specific mechanism of the disease remains unknown, and effective treatments are still lacking. It was reported that Nuclear enriched abundant transcript 1 (NEAT1) obviously was up-regulated in NAFLD model. But the role and underlying mechanism of NEAT1 in NAFLD is unclear.
HepG2 cells were treated by free fatty acids (FFA) and C57BL/6J mice were treated by high-fat diet to establish NAFLD in vitro and in vivo models, respectively. Cell transfection was applied to regulate the expression of NEAT1, ROCK1, and miR-146a-5p. Western blotting and qRT-PCR were used for measuring expression of protein and mRNA level, respectively. Dual luciferase assay was used to detect the target relationship. Oil Red O staining was used to measure the lipid accumulation. HE staining was used for observing pathological feature of liver tissues.
High levels of NEAT1 and ROCK1, and low level of miR-146a-5p were identified in NAFLD models. NEAT1 could target miR-146a-5p to promote ROCK1 expression. Knockdown of NEAT1, overexpression of miR-146a-5p and knockdown of ROCK1 inhibited lipid accumulation through activating AMPK pathway.
NEAT1 may regulate NAFLD through miR-146a-5p targeting ROCK1, and further affect AMPK/SREBP pathway. This study may provide a new thought for the treatment of NAFLD. |
---|---|
AbstractList | Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the specific mechanism of the disease remains unknown, and effective treatments are still lacking. It was reported that Nuclear enriched abundant transcript 1 (NEAT1) obviously was up-regulated in NAFLD model. But the role and underlying mechanism of NEAT1 in NAFLD is unclear.BACKGROUNDNonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the specific mechanism of the disease remains unknown, and effective treatments are still lacking. It was reported that Nuclear enriched abundant transcript 1 (NEAT1) obviously was up-regulated in NAFLD model. But the role and underlying mechanism of NEAT1 in NAFLD is unclear.HepG2 cells were treated by free fatty acids (FFA) and C57BL/6J mice were treated by high-fat diet to establish NAFLD in vitro and in vivo models, respectively. Cell transfection was applied to regulate the expression of NEAT1, ROCK1, and miR-146a-5p. Western blotting and qRT-PCR were used for measuring expression of protein and mRNA level, respectively. Dual luciferase assay was used to detect the target relationship. Oil Red O staining was used to measure the lipid accumulation. HE staining was used for observing pathological feature of liver tissues.METHODSHepG2 cells were treated by free fatty acids (FFA) and C57BL/6J mice were treated by high-fat diet to establish NAFLD in vitro and in vivo models, respectively. Cell transfection was applied to regulate the expression of NEAT1, ROCK1, and miR-146a-5p. Western blotting and qRT-PCR were used for measuring expression of protein and mRNA level, respectively. Dual luciferase assay was used to detect the target relationship. Oil Red O staining was used to measure the lipid accumulation. HE staining was used for observing pathological feature of liver tissues.High levels of NEAT1 and ROCK1, and low level of miR-146a-5p were identified in NAFLD models. NEAT1 could target miR-146a-5p to promote ROCK1 expression. Knockdown of NEAT1, overexpression of miR-146a-5p and knockdown of ROCK1 inhibited lipid accumulation through activating AMPK pathway.RESULTSHigh levels of NEAT1 and ROCK1, and low level of miR-146a-5p were identified in NAFLD models. NEAT1 could target miR-146a-5p to promote ROCK1 expression. Knockdown of NEAT1, overexpression of miR-146a-5p and knockdown of ROCK1 inhibited lipid accumulation through activating AMPK pathway.NEAT1 may regulate NAFLD through miR-146a-5p targeting ROCK1, and further affect AMPK/SREBP pathway. This study may provide a new thought for the treatment of NAFLD.CONCLUSIONNEAT1 may regulate NAFLD through miR-146a-5p targeting ROCK1, and further affect AMPK/SREBP pathway. This study may provide a new thought for the treatment of NAFLD. Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the specific mechanism of the disease remains unknown, and effective treatments are still lacking. It was reported that Nuclear enriched abundant transcript 1 (NEAT1) obviously was up-regulated in NAFLD model. But the role and underlying mechanism of NEAT1 in NAFLD is unclear. HepG2 cells were treated by free fatty acids (FFA) and C57BL/6J mice were treated by high-fat diet to establish NAFLD in vitro and in vivo models, respectively. Cell transfection was applied to regulate the expression of NEAT1, ROCK1, and miR-146a-5p. Western blotting and qRT-PCR were used for measuring expression of protein and mRNA level, respectively. Dual luciferase assay was used to detect the target relationship. Oil Red O staining was used to measure the lipid accumulation. HE staining was used for observing pathological feature of liver tissues. High levels of NEAT1 and ROCK1, and low level of miR-146a-5p were identified in NAFLD models. NEAT1 could target miR-146a-5p to promote ROCK1 expression. Knockdown of NEAT1, overexpression of miR-146a-5p and knockdown of ROCK1 inhibited lipid accumulation through activating AMPK pathway. NEAT1 may regulate NAFLD through miR-146a-5p targeting ROCK1, and further affect AMPK/SREBP pathway. This study may provide a new thought for the treatment of NAFLD. Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the specific mechanism of the disease remains unknown, and effective treatments are still lacking. It was reported that Nuclear enriched abundant transcript 1 (NEAT1) obviously was upregulated in NAFLD model. But the role and underlying mechanism of NEAT1 in NAFLD is unclear.HepG2 cells were treated by free fatty acids (FFA) and C57BL/6J mice were treated by high-fat diet to establish NAFLD in vitro and in vivo models, respectively. Cell transfection was applied to regulate the expression of NEAT1, ROCK1, and miR-146a-5p. Western blotting and qRT-PCR were used for measuring expression of protein and mRNA level, respectively. Dual luciferase assay was used to detect the target relationship. Oil Red O staining was used to measure the lipid accumulation. HE staining was used for observing pathological feature of liver tissues.High levels of NEAT1 and ROCK1, and low level of miR-146a-5p were identified in NAFLD models. NEAT1 could target miR-146a-5p to promote ROCK1 expression. Knockdown of NEAT1, overexpression of miR-146a-5p and knockdown of ROCK1 inhibited lipid accumulation through activating AMPK pathway.NEAT1 may regulate NAFLD through miR-146a-5p targeting ROCK1, and further affect AMPK/SREBP pathway. This study may provide a new thought for the treatment of NAFLD. |
ArticleNumber | 116829 |
Author | Zhang, Xing-Xing Chen, Xi Li, Shi-Jun Tan, Xin-Rui |
Author_xml | – sequence: 1 givenname: Xi surname: Chen fullname: Chen, Xi – sequence: 2 givenname: Xin-Rui surname: Tan fullname: Tan, Xin-Rui – sequence: 3 givenname: Shi-Jun surname: Li fullname: Li, Shi-Jun – sequence: 4 givenname: Xing-Xing orcidid: 0000-0001-5989-3307 surname: Zhang fullname: Zhang, Xing-Xing email: zhangxingxing@csu.edu.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31484042$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUFP3DAQha2Kqiy0P6CXysdesngc23HU02pFC-oKpBU9W15nAl4lcWonK_HvMSztoQd6ssb63tPMe2fkZAgDEvIZ2BIYqIv9smvTkjOolwBK8_odWYCu6oKpEk7IgjEuipIzeUrOUtozxqSsyg_ktAShBRN8QebN4LY3K3pzuboDOsbQhwkTfcDRTt7Rzo--oda5uZ-7_BMGevCWRrx_GYd72vttAULZQo4X29v1T6B-oHlP27nwELrs0dppesxOB4y08Qltwo_kfWu7hJ9e33Py6_vl3fqq2Nz-uF6vNoUTkk8FlhWvbIXCKqhZa2WrG66xEZZDVSu1q6QUrq6BK-CCt3UrcWernZa8VLJR5Tn5evTNh_2eMU2m98lh19kBw5wML0sJPMcE_0e5lsCE0DqjX17ReddjY8boexsfzZ9UMwBHwMWQUsT2LwLMPDdn9iY3Z56bM8fmsqb6R-P89JL4FK3v3lR-OyoxJ3nwGE1yHgeHjY_oJtME_4b6CSbssAk |
CitedBy_id | crossref_primary_10_3390_ncrna6030034 crossref_primary_10_1016_j_jare_2022_08_007 crossref_primary_10_1038_s41434_022_00351_4 crossref_primary_10_1111_liv_14629 crossref_primary_10_3389_fcvm_2021_688546 crossref_primary_10_1111_jocd_13760 crossref_primary_10_1016_j_cellsig_2021_110190 crossref_primary_10_1016_j_ncrna_2023_03_003 crossref_primary_10_1186_s11658_024_00579_5 crossref_primary_10_3390_ncrna8040059 crossref_primary_10_1016_j_theriogenology_2023_11_007 crossref_primary_10_1016_j_bbagrm_2021_194782 crossref_primary_10_3390_cells13050456 crossref_primary_10_1016_j_mce_2023_112061 crossref_primary_10_3389_fmolb_2022_986722 crossref_primary_10_1016_j_prp_2025_155867 crossref_primary_10_3389_fphar_2021_729745 crossref_primary_10_2174_1381612828666220428093207 crossref_primary_10_1002_cbf_4006 crossref_primary_10_1016_j_gastrohep_2023_09_014 crossref_primary_10_1080_21623945_2020_1721970 crossref_primary_10_1016_j_gastre_2024_04_025 crossref_primary_10_1146_annurev_pathol_042320_115255 crossref_primary_10_1016_j_clinre_2023_102095 crossref_primary_10_3390_ijms232012370 crossref_primary_10_3390_nu16050691 crossref_primary_10_2147_DMSO_S333431 crossref_primary_10_1016_j_molmet_2022_101540 crossref_primary_10_1097_SHK_0000000000002294 crossref_primary_10_1016_j_imlet_2020_07_008 crossref_primary_10_3389_fphar_2023_1144836 crossref_primary_10_1002_jcla_24943 crossref_primary_10_1016_j_freeradbiomed_2021_02_033 crossref_primary_10_1016_j_lfs_2023_121894 crossref_primary_10_1007_s13258_021_01103_1 crossref_primary_10_3390_biom13030560 crossref_primary_10_1016_j_imlet_2021_07_004 crossref_primary_10_1177_20420188221132138 crossref_primary_10_1111_liv_15975 crossref_primary_10_1002_jbt_23151 crossref_primary_10_1096_fj_202401464R crossref_primary_10_1080_21655979_2022_2026858 crossref_primary_10_3390_ijms24119168 crossref_primary_10_1007_s11010_021_04269_0 crossref_primary_10_1155_2022_6161694 crossref_primary_10_3390_ijms22147571 crossref_primary_10_1007_s11033_024_10088_5 crossref_primary_10_1016_j_phrs_2021_105846 crossref_primary_10_1186_s12967_020_02577_5 crossref_primary_10_1093_lifemedi_lnae030 crossref_primary_10_3389_fendo_2022_886534 crossref_primary_10_1016_j_clinre_2025_102547 crossref_primary_10_1007_s00430_021_00705_6 crossref_primary_10_1038_s12276_023_01072_3 crossref_primary_10_1038_s41435_023_00205_y crossref_primary_10_1016_j_aohep_2021_100584 crossref_primary_10_3390_ijms23031276 crossref_primary_10_1007_s40618_021_01559_8 crossref_primary_10_1136_egastro_2024_100115 crossref_primary_10_1124_dmd_122_001065 crossref_primary_10_1261_rna_079580_123 crossref_primary_10_1042_BSR20193299 crossref_primary_10_1016_j_ajpath_2024_02_006 crossref_primary_10_1186_s12986_021_00552_5 crossref_primary_10_3389_fvets_2025_1559727 crossref_primary_10_37349_edd_2023_00025 crossref_primary_10_1080_15592294_2023_2239592 crossref_primary_10_1089_jir_2023_0162 crossref_primary_10_1007_s12013_024_01555_8 crossref_primary_10_1055_a_2532_4370 crossref_primary_10_3748_wjg_v28_i35_5111 crossref_primary_10_1016_j_omtn_2024_102184 crossref_primary_10_1007_s12094_024_03700_4 crossref_primary_10_1186_s12944_022_01662_6 crossref_primary_10_2147_JIR_S338162 |
Cites_doi | 10.1016/j.phrs.2018.03.017 10.1007/s10616-010-9290-0 10.1016/j.jnutbio.2010.10.002 10.1002/jcb.26317 10.1186/s12967-015-0383-6 10.1007/s13238-013-3001-5 10.1111/j.1872-034X.2008.00382.x 10.1172/JCI63562 10.3748/wjg.v20.i26.8393 10.1002/hep.26672 10.2147/OTT.S116319 10.1002/med.21515 10.1016/S2213-8587(14)70032-4 10.1016/j.molcel.2009.01.026 10.1038/ijo.2017.21 10.1161/HYPERTENSIONAHA.113.02296 10.1007/s00424-016-1804-y 10.1152/ajpendo.00619.2013 10.1002/hep.27406 10.3748/wjg.14.7240 10.1073/pnas.1222643110 10.1016/j.cell.2004.12.035 10.1038/s41467-018-07287-7 10.3349/ymj.2018.59.9.1064 10.1128/MCB.00702-15 10.1080/21691401.2019.1604536 10.1007/s11655-011-0603-8 10.1093/jb/mvp104 10.1146/annurev.med.59.053006.104707 10.1038/srep16163 10.1002/pros.23068 10.1089/jmf.2015.3623 |
ContentType | Journal Article |
Copyright | 2019 Elsevier Inc. Copyright © 2019 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2019 Elsevier Inc. – notice: Copyright © 2019 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION NPM 7X8 7S9 L.6 |
DOI | 10.1016/j.lfs.2019.116829 |
DatabaseName | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic AGRICOLA PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Biology |
EISSN | 1879-0631 |
ExternalDocumentID | 31484042 10_1016_j_lfs_2019_116829 S0024320519307568 |
Genre | Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 4.4 457 5GY 5RE 5VS 6TJ 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAXUO ABFNM ABFRF ABJNI ABLJU ABLVK ABMAC ABMZM ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACIWK ACPRK ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFRAH AFTJW AFXIZ AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV C45 CNWQP CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IH2 IHE J1W K-O KOM L7B LCYCR M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SDP SES SPCBC SSH SSP SSZ T5K TEORI YZZ ~G- .55 .GJ 29L 3O- 53G AAHBH AAQXK AATTM AAXKI AAYWO AAYXX ABWVN ABXDB ACIEU ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFFNX AFJKZ AFPUW AGCQF AGHFR AGQPQ AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HMG HMT HVGLF HZ~ H~9 J5H MVM R2- SEW SIN SPT WUQ X7M Y6R YYP ZGI ZKB ZXP ZY4 NPM 7X8 EFKBS 7S9 L.6 |
ID | FETCH-LOGICAL-c452t-e3727a7e4a6190fa5f8d28ed4a217966b7554c991261242f9f5eba7b852365d63 |
IEDL.DBID | AIKHN |
ISSN | 0024-3205 1879-0631 |
IngestDate | Fri Sep 05 05:18:12 EDT 2025 Fri Sep 05 14:39:16 EDT 2025 Thu Apr 03 07:02:55 EDT 2025 Thu Apr 24 23:09:30 EDT 2025 Tue Jul 01 04:29:52 EDT 2025 Fri Feb 23 02:29:32 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | miR-146a-5p NAFLD ROCK1 NEAT1 |
Language | English |
License | Copyright © 2019 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c452t-e3727a7e4a6190fa5f8d28ed4a217966b7554c991261242f9f5eba7b852365d63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-5989-3307 |
PMID | 31484042 |
PQID | 2285104488 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2335120021 proquest_miscellaneous_2285104488 pubmed_primary_31484042 crossref_primary_10_1016_j_lfs_2019_116829 crossref_citationtrail_10_1016_j_lfs_2019_116829 elsevier_sciencedirect_doi_10_1016_j_lfs_2019_116829 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-10-15 |
PublicationDateYYYYMMDD | 2019-10-15 |
PublicationDate_xml | – month: 10 year: 2019 text: 2019-10-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Life sciences (1973) |
PublicationTitleAlternate | Life Sci |
PublicationYear | 2019 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Ugi (bb0160) 2009; 146 Huang (bb0005) 2018; 128 Wang (bb0055) 2018; 119 Latorre (bb0090) 2017; 41 Cai, Zhang, Li (bb0115) 2019; 39 Im (bb0120) 2016; 19 Iacono (bb0025) 2011; 22 Xu (bb0105) 2015; 75 Lee (bb0100) 2014; 306 Sun (bb0145) 2013; 110 Cheng (bb0125) 2011; 17 Yuan (bb0050) 2015; 13 Liang (bb0150) 2013; 4 Gernapudi (bb0075) 2016; 36 Yao (bb0035) 2018; 131 Yki-Jarvinen (bb0020) 2014; 2 Melissari, Grote (bb0045) 2016; 468 Garzon, Calin, Croce (bb0070) 2009; 60 Kajikawa (bb0095) 2014; 63 Clemson (bb0060) 2009; 33 Zhang (bb0140) 2018; 59 Mang (bb0040) 2017; 10 Wang (bb0110) 2008; 14 Birkenfeld, Shulman (bb0030) 2014; 59 Xu (bb0135) 2010; 62 Toshikuni, Tsutsumi, Arisawa (bb0015) 2014; 20 Choi (bb0130) 2018; 9 Higuchi (bb0155) 2008; 38 Lewis, Burge, Bartel (bb0080) 2005; 120 Wang (bb0010) 2014; 60 Fu (bb0065) 2019; 47 Du (bb0085) 2015; 5 Yao (10.1016/j.lfs.2019.116829_bb0035) 2018; 131 Huang (10.1016/j.lfs.2019.116829_bb0005) 2018; 128 Wang (10.1016/j.lfs.2019.116829_bb0010) 2014; 60 Mang (10.1016/j.lfs.2019.116829_bb0040) 2017; 10 Xu (10.1016/j.lfs.2019.116829_bb0135) 2010; 62 Lewis (10.1016/j.lfs.2019.116829_bb0080) 2005; 120 Cai (10.1016/j.lfs.2019.116829_bb0115) 2019; 39 Liang (10.1016/j.lfs.2019.116829_bb0150) 2013; 4 Cheng (10.1016/j.lfs.2019.116829_bb0125) 2011; 17 Ugi (10.1016/j.lfs.2019.116829_bb0160) 2009; 146 Fu (10.1016/j.lfs.2019.116829_bb0065) 2019; 47 Lee (10.1016/j.lfs.2019.116829_bb0100) 2014; 306 Melissari (10.1016/j.lfs.2019.116829_bb0045) 2016; 468 Kajikawa (10.1016/j.lfs.2019.116829_bb0095) 2014; 63 Latorre (10.1016/j.lfs.2019.116829_bb0090) 2017; 41 Iacono (10.1016/j.lfs.2019.116829_bb0025) 2011; 22 Wang (10.1016/j.lfs.2019.116829_bb0110) 2008; 14 Sun (10.1016/j.lfs.2019.116829_bb0145) 2013; 110 Gernapudi (10.1016/j.lfs.2019.116829_bb0075) 2016; 36 Zhang (10.1016/j.lfs.2019.116829_bb0140) 2018; 59 Im (10.1016/j.lfs.2019.116829_bb0120) 2016; 19 Clemson (10.1016/j.lfs.2019.116829_bb0060) 2009; 33 Yuan (10.1016/j.lfs.2019.116829_bb0050) 2015; 13 Birkenfeld (10.1016/j.lfs.2019.116829_bb0030) 2014; 59 Higuchi (10.1016/j.lfs.2019.116829_bb0155) 2008; 38 Toshikuni (10.1016/j.lfs.2019.116829_bb0015) 2014; 20 Du (10.1016/j.lfs.2019.116829_bb0085) 2015; 5 Garzon (10.1016/j.lfs.2019.116829_bb0070) 2009; 60 Yki-Jarvinen (10.1016/j.lfs.2019.116829_bb0020) 2014; 2 Wang (10.1016/j.lfs.2019.116829_bb0055) 2018; 119 Choi (10.1016/j.lfs.2019.116829_bb0130) 2018; 9 Xu (10.1016/j.lfs.2019.116829_bb0105) 2015; 75 |
References_xml | – volume: 131 start-page: 51 year: 2018 end-page: 60 ident: bb0035 article-title: Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway publication-title: Pharmacol. Res. – volume: 13 start-page: 24 year: 2015 ident: bb0050 article-title: Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles publication-title: J. Transl. Med. – volume: 60 start-page: 167 year: 2009 end-page: 179 ident: bb0070 article-title: MicroRNAs in cancer publication-title: Annu. Rev. Med. – volume: 110 start-page: 3387 year: 2013 end-page: 3392 ident: bb0145 article-title: Long noncoding RNAs regulate adipogenesis publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 22 start-page: 699 year: 2011 end-page: 711 ident: bb0025 article-title: Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms publication-title: J. Nutr. Biochem. – volume: 119 start-page: 1567 year: 2018 end-page: 1574 ident: bb0055 article-title: Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway publication-title: J. Cell. Biochem. – volume: 146 start-page: 541 year: 2009 end-page: 547 ident: bb0160 article-title: Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression and consequent hypertriglyceridaemia publication-title: J. Biochem. – volume: 33 start-page: 717 year: 2009 end-page: 726 ident: bb0060 article-title: An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles publication-title: Mol. Cell – volume: 62 start-page: 473 year: 2010 end-page: 481 ident: bb0135 article-title: Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake publication-title: Cytotechnology – volume: 306 start-page: E332 year: 2014 end-page: E343 ident: bb0100 article-title: ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance publication-title: Am. J. Physiol. Endocrinol. Metab. – volume: 59 start-page: 1064 year: 2018 end-page: 1071 ident: bb0140 article-title: S100A4 gene is crucial for methionine-choline-deficient diet-induced non-alcoholic fatty liver disease in mice publication-title: Yonsei Med. J. – volume: 17 start-page: 361 year: 2011 end-page: 368 ident: bb0125 article-title: Structural shifts of gut flora in rat acute alcoholic liver injury and jianpi huoxue decoction’s effect displayed by ERIC-PCR fingerprint publication-title: Chin. J. Integr. Med. – volume: 38 start-page: 1122 year: 2008 end-page: 1129 ident: bb0155 article-title: Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease publication-title: Hepatol. Res. – volume: 5 start-page: 16163 year: 2015 ident: bb0085 article-title: MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a publication-title: Sci. Rep. – volume: 10 start-page: 1003 year: 2017 end-page: 1016 ident: bb0040 article-title: Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells publication-title: Onco. Targets Ther. – volume: 14 start-page: 7240 year: 2008 end-page: 7246 ident: bb0110 article-title: Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease publication-title: World J. Gastroenterol. – volume: 468 start-page: 945 year: 2016 end-page: 958 ident: bb0045 article-title: Roles for long non-coding RNAs in physiology and disease publication-title: Pflugers Arch. – volume: 20 start-page: 8393 year: 2014 end-page: 8406 ident: bb0015 article-title: Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease publication-title: World J. Gastroenterol. – volume: 47 start-page: 1782 year: 2019 end-page: 1787 ident: bb0065 article-title: Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells publication-title: Artif. Cells Nanomed. Biotechnol. – volume: 39 start-page: 328 year: 2019 end-page: 348 ident: bb0115 article-title: Progress and challenges in the prevention and control of nonalcoholic fatty liver disease publication-title: Med. Res. Rev. – volume: 9 start-page: 4824 year: 2018 ident: bb0130 article-title: Serotonin signals through a gut-liver axis to regulate hepatic steatosis publication-title: Nat. Commun. – volume: 75 start-page: 1896 year: 2015 end-page: 1903 ident: bb0105 article-title: Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1 publication-title: Prostate – volume: 128 start-page: 5335 year: 2018 end-page: 5350 ident: bb0005 article-title: Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition publication-title: J. Clin. Invest. – volume: 36 start-page: 30 year: 2016 end-page: 38 ident: bb0075 article-title: MicroRNA 140 promotes expression of long noncoding RNA NEAT1 in adipogenesis publication-title: Mol. Cell. Biol. – volume: 120 start-page: 15 year: 2005 end-page: 20 ident: bb0080 article-title: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets publication-title: Cell – volume: 63 start-page: 856 year: 2014 end-page: 864 ident: bb0095 article-title: Rho-associated kinase activity is a predictor of cardiovascular outcomes publication-title: Hypertension – volume: 41 start-page: 620 year: 2017 end-page: 630 ident: bb0090 article-title: Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD publication-title: Int. J. Obes. – volume: 60 start-page: 2099 year: 2014 end-page: 2108 ident: bb0010 article-title: The global burden of liver disease: the major impact of China publication-title: Hepatology – volume: 59 start-page: 713 year: 2014 end-page: 723 ident: bb0030 article-title: Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes publication-title: Hepatology – volume: 4 start-page: 325 year: 2013 end-page: 330 ident: bb0150 article-title: Nuclear microRNAs and their unconventional role in regulating non-coding RNAs publication-title: Protein Cell – volume: 2 start-page: 901 year: 2014 end-page: 910 ident: bb0020 article-title: Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome publication-title: Lancet Diabetes Endocrinol. – volume: 19 start-page: 495 year: 2016 end-page: 503 ident: bb0120 article-title: Water extract of Dolichos lablab attenuates hepatic lipid accumulation in a cellular nonalcoholic fatty liver disease model publication-title: J. Med. Food – volume: 131 start-page: 51 year: 2018 ident: 10.1016/j.lfs.2019.116829_bb0035 article-title: Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2018.03.017 – volume: 62 start-page: 473 issue: 5 year: 2010 ident: 10.1016/j.lfs.2019.116829_bb0135 article-title: Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake publication-title: Cytotechnology doi: 10.1007/s10616-010-9290-0 – volume: 22 start-page: 699 issue: 8 year: 2011 ident: 10.1016/j.lfs.2019.116829_bb0025 article-title: Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms publication-title: J. Nutr. Biochem. doi: 10.1016/j.jnutbio.2010.10.002 – volume: 119 start-page: 1567 issue: 2 year: 2018 ident: 10.1016/j.lfs.2019.116829_bb0055 article-title: Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway publication-title: J. Cell. Biochem. doi: 10.1002/jcb.26317 – volume: 13 start-page: 24 year: 2015 ident: 10.1016/j.lfs.2019.116829_bb0050 article-title: Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles publication-title: J. Transl. Med. doi: 10.1186/s12967-015-0383-6 – volume: 4 start-page: 325 issue: 5 year: 2013 ident: 10.1016/j.lfs.2019.116829_bb0150 article-title: Nuclear microRNAs and their unconventional role in regulating non-coding RNAs publication-title: Protein Cell doi: 10.1007/s13238-013-3001-5 – volume: 38 start-page: 1122 issue: 11 year: 2008 ident: 10.1016/j.lfs.2019.116829_bb0155 article-title: Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease publication-title: Hepatol. Res. doi: 10.1111/j.1872-034X.2008.00382.x – volume: 128 start-page: 5335 issue: 12 year: 2018 ident: 10.1016/j.lfs.2019.116829_bb0005 article-title: Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition publication-title: J. Clin. Invest. doi: 10.1172/JCI63562 – volume: 20 start-page: 8393 issue: 26 year: 2014 ident: 10.1016/j.lfs.2019.116829_bb0015 article-title: Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v20.i26.8393 – volume: 59 start-page: 713 issue: 2 year: 2014 ident: 10.1016/j.lfs.2019.116829_bb0030 article-title: Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes publication-title: Hepatology doi: 10.1002/hep.26672 – volume: 10 start-page: 1003 year: 2017 ident: 10.1016/j.lfs.2019.116829_bb0040 article-title: Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells publication-title: Onco. Targets Ther. doi: 10.2147/OTT.S116319 – volume: 39 start-page: 328 issue: 1 year: 2019 ident: 10.1016/j.lfs.2019.116829_bb0115 article-title: Progress and challenges in the prevention and control of nonalcoholic fatty liver disease publication-title: Med. Res. Rev. doi: 10.1002/med.21515 – volume: 2 start-page: 901 issue: 11 year: 2014 ident: 10.1016/j.lfs.2019.116829_bb0020 article-title: Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome publication-title: Lancet Diabetes Endocrinol. doi: 10.1016/S2213-8587(14)70032-4 – volume: 33 start-page: 717 issue: 6 year: 2009 ident: 10.1016/j.lfs.2019.116829_bb0060 article-title: An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles publication-title: Mol. Cell doi: 10.1016/j.molcel.2009.01.026 – volume: 41 start-page: 620 issue: 4 year: 2017 ident: 10.1016/j.lfs.2019.116829_bb0090 article-title: Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD publication-title: Int. J. Obes. doi: 10.1038/ijo.2017.21 – volume: 63 start-page: 856 issue: 4 year: 2014 ident: 10.1016/j.lfs.2019.116829_bb0095 article-title: Rho-associated kinase activity is a predictor of cardiovascular outcomes publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.113.02296 – volume: 468 start-page: 945 issue: 6 year: 2016 ident: 10.1016/j.lfs.2019.116829_bb0045 article-title: Roles for long non-coding RNAs in physiology and disease publication-title: Pflugers Arch. doi: 10.1007/s00424-016-1804-y – volume: 306 start-page: E332 issue: 3 year: 2014 ident: 10.1016/j.lfs.2019.116829_bb0100 article-title: ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00619.2013 – volume: 60 start-page: 2099 issue: 6 year: 2014 ident: 10.1016/j.lfs.2019.116829_bb0010 article-title: The global burden of liver disease: the major impact of China publication-title: Hepatology doi: 10.1002/hep.27406 – volume: 14 start-page: 7240 issue: 47 year: 2008 ident: 10.1016/j.lfs.2019.116829_bb0110 article-title: Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease publication-title: World J. Gastroenterol. doi: 10.3748/wjg.14.7240 – volume: 110 start-page: 3387 issue: 9 year: 2013 ident: 10.1016/j.lfs.2019.116829_bb0145 article-title: Long noncoding RNAs regulate adipogenesis publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1222643110 – volume: 120 start-page: 15 issue: 1 year: 2005 ident: 10.1016/j.lfs.2019.116829_bb0080 article-title: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets publication-title: Cell doi: 10.1016/j.cell.2004.12.035 – volume: 9 start-page: 4824 issue: 1 year: 2018 ident: 10.1016/j.lfs.2019.116829_bb0130 article-title: Serotonin signals through a gut-liver axis to regulate hepatic steatosis publication-title: Nat. Commun. doi: 10.1038/s41467-018-07287-7 – volume: 59 start-page: 1064 issue: 9 year: 2018 ident: 10.1016/j.lfs.2019.116829_bb0140 article-title: S100A4 gene is crucial for methionine-choline-deficient diet-induced non-alcoholic fatty liver disease in mice publication-title: Yonsei Med. J. doi: 10.3349/ymj.2018.59.9.1064 – volume: 36 start-page: 30 issue: 1 year: 2016 ident: 10.1016/j.lfs.2019.116829_bb0075 article-title: MicroRNA 140 promotes expression of long noncoding RNA NEAT1 in adipogenesis publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.00702-15 – volume: 47 start-page: 1782 issue: 1 year: 2019 ident: 10.1016/j.lfs.2019.116829_bb0065 article-title: Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells publication-title: Artif. Cells Nanomed. Biotechnol. doi: 10.1080/21691401.2019.1604536 – volume: 17 start-page: 361 issue: 5 year: 2011 ident: 10.1016/j.lfs.2019.116829_bb0125 article-title: Structural shifts of gut flora in rat acute alcoholic liver injury and jianpi huoxue decoction’s effect displayed by ERIC-PCR fingerprint publication-title: Chin. J. Integr. Med. doi: 10.1007/s11655-011-0603-8 – volume: 146 start-page: 541 issue: 4 year: 2009 ident: 10.1016/j.lfs.2019.116829_bb0160 article-title: Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression and consequent hypertriglyceridaemia publication-title: J. Biochem. doi: 10.1093/jb/mvp104 – volume: 60 start-page: 167 year: 2009 ident: 10.1016/j.lfs.2019.116829_bb0070 article-title: MicroRNAs in cancer publication-title: Annu. Rev. Med. doi: 10.1146/annurev.med.59.053006.104707 – volume: 5 start-page: 16163 year: 2015 ident: 10.1016/j.lfs.2019.116829_bb0085 article-title: MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a publication-title: Sci. Rep. doi: 10.1038/srep16163 – volume: 75 start-page: 1896 issue: 16 year: 2015 ident: 10.1016/j.lfs.2019.116829_bb0105 article-title: Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1 publication-title: Prostate doi: 10.1002/pros.23068 – volume: 19 start-page: 495 issue: 5 year: 2016 ident: 10.1016/j.lfs.2019.116829_bb0120 article-title: Water extract of Dolichos lablab attenuates hepatic lipid accumulation in a cellular nonalcoholic fatty liver disease model publication-title: J. Med. Food doi: 10.1089/jmf.2015.3623 |
SSID | ssj0005573 |
Score | 2.5502927 |
Snippet | Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the specific mechanism of the... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 116829 |
SubjectTerms | fatty liver free fatty acids gene expression high fat diet lipids liver luciferase messenger RNA mice miR-146a-5p NAFLD NEAT1 quantitative polymerase chain reaction reverse transcriptase polymerase chain reaction ROCK1 staining transfection Western blotting |
Title | LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease |
URI | https://dx.doi.org/10.1016/j.lfs.2019.116829 https://www.ncbi.nlm.nih.gov/pubmed/31484042 https://www.proquest.com/docview/2285104488 https://www.proquest.com/docview/2335120021 |
Volume | 235 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ra9swED7SlMFeytJ1W7qtqLCHdqDFlmRbfgyhJVu7FEILfTOyLFGX1DOtU-jLfvtOttwx2PKwR4uTfOiku--40x3AJ-lEq0VOExHHVOjQ0lwYTkWitOWpCbR0752_L-L5lfh2HV0PYNa_hXFplV73dzq91dZ-ZOJ3c1KXpXvjywRnLQRBuxfLLdhmaO3lELanX8_mi9-ZHpEPNDNB3YQ-uNmmea2sK9odpqg7YtkCzb-ap3_Bz9YMnb6CHY8fybRjcQQDU-3Ci66j5NMujPxdfSBHvqD08WtYn1d6uZiSxcn0MiR1m4CHFDfGZVNrsirrsiBK6_Wd7-VFHktF7rsu9WjayF25pKjrFI3qyfJidhaSsiKVw_Btf11cw6qmecKV8GIQH_PZg6vTk8vZnPp2C1SLiDXUcMQyKjFCoVMVWBVZWTBpCqHQbUGvKE8QemjEk67qmGA2tZHJVZJL9GXjqIj5Gxjir807IAjZXS91jqxxkYdBWgTWoK-ZJEXKYh2MIeh3OdO-FrlribHK-qSz2wwFkznBZJ1gxvD5eUrdFeLYRCx60WV_nKYMDcWmaYe9mDO8ZS50oirzY41EDJFpgK6s3EDDOaInB5rG8LY7I8-c4k6gJy3Y_v8x9h5eui9nM8PoAwyb-7X5iGCoyQ9g68vP8MAf-V_TygO5 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-6lLG9jLX7ytptGuxhG4jYkvz1GEJLuqQehBT6JmRZoh6pZzpn0P9-J1vuGLR52Kt9soVOuvsdd7ofwKfUqVaLgiYijqnQoaWFMJyKRGnLMxPo1N13Ps_j-YX4dhld7sFsuAvjyiq97e9temet_ZOJX81JU1Xuji8TnHUQBP1enD6CfeFIrUewPz1bzPO_lR6RTzQzQd2AIbnZlXltrGvaHWZoO-K0A5r3uqeH4Gfnhk6fwzOPH8m0n-IB7Jn6EB73jJK3h3Dgz-ov8tk3lP7yArbLWq_yKclPpuuQNF0BHkpcGVdNrcmmaqqSKK23157Li_yuFLnpWerRtZHrakXR1ikaNZPV99kiJFVNaofhO35d_IZVbXuLX8KDQXzO5yVcnJ6sZ3Pq6RaoFhFrqeGIZVRihMKgKrAqsmnJUlMKhWELRkVFgtBDI550XccEs5mNTKGSIsVYNo7KmL-CEf7avAGCkN1xqXOcGhdFGGRlYA3GmklSZizWwRiCYZWl9r3IHSXGRg5FZz8kKkY6xcheMWP4ejek6Rtx7BIWg-rkP7tJoqPYNezjoGaJp8ylTlRtfm5RiCEyDTCUTXfIcI7oyYGmMbzu98jdTHElMJIW7O3_TewDPJmvz5dyeZYvjuCpe-P8Zxgdw6i92Zp3CIza4r3f-H8A8MYFnw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LncRNA+NEAT1+promotes+hepatic+lipid+accumulation+via+regulating+miR-146a-5p%2FROCK1+in+nonalcoholic+fatty+liver+disease&rft.jtitle=Life+sciences+%281973%29&rft.au=Chen%2C+Xi&rft.au=Tan%2C+Xin-Rui&rft.au=Li%2C+Shi-Jun&rft.au=Zhang%2C+Xing-Xing&rft.date=2019-10-15&rft.issn=1879-0631&rft.eissn=1879-0631&rft.volume=235&rft.spage=116829&rft_id=info:doi/10.1016%2Fj.lfs.2019.116829&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0024-3205&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0024-3205&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0024-3205&client=summon |